Clinical Trial

Outcomes of Full Pulpotomy Treatment in Teeth With Symptoms of Irreversible Pulpitis

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2025 (before its estimated December 26, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial is to learn how successful Biodentine and NeoPutty dental filling materials are in treating dental pulp inflammation in adults. It will also provide information about post-treatment pain. The main questions it aims to answer are: Do Biodentine and NeoPutty dental filling materials treat dental pulpitis in participants? Do they reduce the need for root canal treatment? After the application of Biodentine and NeoPutty dental filling materials to the participants, the pain and symptoms that cause pain may not decrease. In this case, the tooth may be treated with root canal treatment. The researchers will compare the clinical success of Biodentine and NeoPutty dental filling materials with each other. Participants will undergo a single-session pulpotomy treatment with the dental filling materials mentioned above. Clinical and radiographic follow-ups will then be performed at 3, 6 and 12 months, and records will be kept.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-25.
Trial Details
NCT Number NCT06802536
Lead Sponsor Firat University
Conditions Pulpitis - Irreversible
Enrollment 60 participants
Start Date 2024-04-15
Primary Completion 2025-12-26 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-23